A personal installment loan generally supplies a lump sum repaid on a schedule. An unsecured personal line lets you borrow up to a limit over time; compare changing balances, rate terms and access fees rather than assuming flexibility is free.
Which structure matches the expense pattern?
A known single expense and a series of uncertain costs create different cash needs. With a line, you may pay interest only on drawn balances under its terms, but repeated access can make it harder to define a payoff date. A lump-sum loan creates an immediate balance even if some proceeds sit unused. Neither structure establishes approval or availability.
What does a draw-and-repay example show?
| Step | Outstanding principal | One-month interest at 1.5% |
|---|---|---|
| Draw $2,000 from a $6,000 limit | $2,000 | $30.00 |
| Repay $500 principal, then draw $1,000 | $2,500 | $37.50 |
The second balance is $2,000−$500+$1,000. This is not a daily-balance billing calculation or a minimum-payment rule. Real dates, compounding, rate changes and fees alter the result. The remaining credit limit is also different from a household payment allowance.
What terms deserve special attention on a line?
- Whether APR can change and how the variable rate is determined.
- Any annual, access, draw, late or other fee.
- How the minimum payment is calculated and whether it meaningfully reduces principal.
- Whether access can be suspended and what repayment continues afterward.
How can you avoid borrowing without an endpoint?
Write a total spending cap and a target payoff schedule before the first draw. After each new charge, recalculate the balance and installment needed to meet that endpoint. The CFPB personal-line sources support reviewing APR changes and access fees. For a home-equity line, the collateral question adds a different risk; this page’s line example is unsecured.
Sources supporting this explanation
Sources checked 2026-10-24. Examples are hypothetical BYL calculations or planning worksheets;they are not observed lender prices,offers or approval criteria.